2nd Quarter - Report

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

Firm
Client
Income
—
Expenses
$40,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Opposing House and Senate Patent Reform of 2008 Legislation.

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
SARAH G KAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey

LobbyistCovered position, as disclosed
ROBERT D FRANKS Member of Congress (1992-2000)
STEVE ISSENMAN —
SARAH G KAN House Staff (1999-2002)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Torts TOR

Opposition to the Medical Device Safety Act of 2008.

LobbyistCovered position, as disclosed
SARAH G KAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Advocating for patent protections in trade bills and in foreign government operations

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
SARAH G KAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Advocating on behalf of Medicare Part D open access and encouraging open market access to medications

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
STEVE ISSENMAN —
SARAH G KAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

recognizing the importance of biomedical research, diagnostics, and technologies.

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
STEVE ISSENMAN —
SARAH G KAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.